Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

Daniel V.T. Catenacci, Yoon‐Koo Kang, Haeseong Park, Hope E. Uronis, Keun-Wook Lee, Matthew Chau Hsien Ng, Peter C. Enzinger, Se Hoon Park, Philip J. Gold, Jill Lacy, Howard S. Höchster, Sang Cheul Oh, Yeul Hong Kim, Kristen A. Marrone, Ronan J. Kelly, Rosalyn A. Juergens, Jong Gwang Kim, Johanna C. Bendell, Thierry Alcindor, Sun Jin Sym, Eun‐Kee Song, Cheng Ean Chee, Yee Chao, Sunnie S. Y. Kim, A. Craig Lockhart, Keith L. Knutson, Jennifer Yen, Aleksandra Franovic, Jeffrey L. Nordstrom, Daner Li, Jon M. Wigginton, Jan Davidson‐Moncada, Minori Koshiji Rosales, Yung‐Jue Bang